Emerging Non-Clinical Biostatistics in Biopharmaceutical Development and Manufacturing - Chapman & Hall/CRC Biostatistics Series

Emerging Non-Clinical Biostatistics in Biopharmaceutical Development and Manufacturing

Emerging Non-Clinical Biostatistics in Biopharmaceutical Development and Manufacturing - Chapman & Hall/CRC Biostatistics Series

(Author)
hardback
Published: 1 December, 2016
Standard worldwide delivery by Thu, July 23 - Tue, July 28
Order within 0
Condition: NEW
$131.50
RRP $153.87
You save $22.37 (15%)
Price includes shipping
Available 1 in stock
- +
Add to basket Wishlist This
FREE Returns within 30 days
More Details

Popular Books by Harry Yang

View All Books by Harry Yang
Real-World Evidence in Drug Development and Evaluation
Real-World Evidence in Drug Development and Evaluation
Harry Yang
$73.28
New
Add to basket
Real-World Evidence in Drug Development and Evaluation
Real-World Evidence in Drug Development and Evaluation
Harry Yang
$164.94 $187.32
New
Add to basket
Bayesian Analysis with R for Drug Development
Bayesian Analysis with R for Drug Development
Harry Yang
$58.62 $61.54
New
Add to basket
Biosimilars
Biosimilars
Harry Yang
$226.77
New
Add to basket
Statistics for Biotechnology Process Development
Statistics for Biotechnology Process Development
Harry Yang
$165.12 $167.25
New
Add to basket
Statistical Methods in Drug Combination Studies
Statistical Methods in Drug Combination Studies
Harry Yang
$173.71 $207.39
New
Add to basket
Statistical Methods in Drug Combination Studies
Statistical Methods in Drug Combination Studies
Harry Yang
$61.67 $64.21
New
Add to basket
Emerging Non-Clinical Biostatistics in Biopharmaceutical Development and Manufacturing
Emerging Non-Clinical Biostatistics in Biopharmaceutical Development and Manufacturing
Harry Yang
$62.94 $65.55
New
Add to basket
Statistical Methods for Immunogenicity Assessment
Statistical Methods for Immunogenicity Assessment
Harry Yang
$60.89 $64.21
New
Add to basket
Statistics for Biotechnology Process Development
Statistics for Biotechnology Process Development
Harry Yang
$68.05 $70.90
New
Add to basket

Description

The premise of Quality by Design (QbD) is that the quality of the pharmaceutical product should be based upon a thorough understanding of both the product and the manufacturing process. This state-of-the-art book provides a single source of information on emerging statistical approaches to QbD and risk-based pharmaceutical development. A comprehensive resource, it combines in-depth explanations of advanced statistical methods with real-life case studies that illustrate practical applications of these methods in QbD implementation.

See more

More Details

Type Book
ISBN13 9781498704151
ISBN10 1498704158
Number Of Pages 386
Item Weight 703 g
Publisher / Reseller Taylor & Francis Inc
Format hardback
See More +

Author's Bio

Harry Yang, Ph.D., is senior director and head of the Non-Clinical Biostatistics Group at MedImmune, the global biologics arm of AstraZeneca headquartered in Gaithersburg, Maryland.

Show more